Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism MFN2 agonists(mitofusin 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Charcot-Marie-Tooth Disease, Type 2A | Preclinical | US | 20 Apr 2018 |